Microtubules play an important role in establishing cellular architecture. Neuronal microtubules are considered to have a role in dendrite and axon formation.
The 255-kDa microtubule-associated protein (MAP) 1B (MAP1B) is a member of a group of proteins that are predominantly associated with microtubules in neurons and glia (1, 2) . MAPlB is a complex of three proteins of which two, the heavy chain and a light chain (LC1), are derived respectively from the N terminus (amino acids 2201-2216) and the C terminus (amino acids 247-262) of a polyprotein precursor (3) (4) (5) . The heavy chain contains an N-terminal LC1-binding domain, a microtubule-binding domain (amino acids 589-787), and a relatively large negatively charged C-terminal region which forms filamentous bridges between adjacent microtubules (1) (2) (3) (4) (5) (6) . MAPlB is expressed at high levels during embryogenesis and peaks at 2-3 days after birth. Two to three weeks after birth, the expression of MAPlB decreases and expression of other MAPs such as MAPlA increases (7) (8) (9) . During development this protein is found in areas which show extensive axonal growth, including motor neurons, retinal ganglion cells, olfactory epithelium, the nerve layer of the olfactory bulb, and the mossy fibers of the hippocampus (10-13). In adult brain, MAPlB is found in selected areas where there is active neuronal outgrowth, including the olfactory bulb and regions of the brain where neuronal plasticity may have a role such as the hippocampus as well as in the dendrites of Purkinje cells in the cerebellum (6, 9) . Although the patterns of expression of MAPlB in vivo and experiments
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with cultured pheochromocytoma (PC12) cells suggest an important role for this protein in axonal and neurite outgrowth (14-16), there is no definitive information concerning its function in normal growth and development. To examine the role of MAPlB we introduced a targeted mutation in the Maplb gene of the mouse. We show that this mutation in the homozygous state results in embryonic lethality, and a subset of the heterozygous animals exhibit a spectrum of neurological phenotypic abnormalities including loss of visual acuity, ataxic gait, spastic tremor of the hindlimbs, and an overall reduction in body weight of up to 50%. Immunohistochemical analysis of the affected animals revealed significant changes in MAPlB protein expression in several parts of the brain. sodium phosphate buffer, pH 7.4. This material was embedded in paraffin, and 10-,um sections were prepared and stained with cresyl violet. Immunohistochemistry. For immunohistochemistry, adult animals were anesthetized and perfused intracardially with Tyrode's solution, then 4% paraformaldehyde/0.1% glutaraldehyde solution in pH 7.4 phosphate buffer, followed by brief perfusions with 10% and 30% sucrose solutions. The brains were immersed overnight in 30% sucrose. Sections 50 ,tm thick were cut sagitally through the cerebellum on a freezing microtome. Similar-thickness coronal sections were obtained for the other parts of the brain. The sections were rinsed in 0.01 M phosphate-buffered saline (PBS), pH 7.4, treated with 0.3% H202 in PBS, then incubated for 1 hr in 5% milk solids/0.1% Triton X-100 in PBS. The sections were incubated with primary antibody in 5% milk solids/PBS overnight at 4°C. The MAPlB antibodies, 3G5 and 6D4, were provided by Lester Binder (University of Alabama). 3G5 is directed against a nonphosphorylated epitope and 6D4 detects a phosphorylated epitope. The MAPlA antibody is a mouse monoclonal purchased from Sigma. On the following day, the sections were processed with a mouse IgG Vectastain Elite kit (Vector Laboratories) and visualized with diaminobenzidine.
MATERIALS AND METHODS
Antibodies. Monoclonal antibodies 3G5 (MAP1B), AP14 (MAP2) and Alz5O were used to visualize cytoskeletal proteins after transfer to nitrocellulose. Alz5O reacts with all forms of tau and has some cross-reactivity with MAP2 (18), as well as with a 120-kDa protein we have termed FAC. LC1 and LC2 antigens were purified from taxol-assembled rat brain microtubules by SDS/PAGE. Production of rabbit antiserum to LC3 expressed in Escherichia coli was previously described (19). Polypeptide composed of the first 150 amino acids of mouse MAPlB fused to glutathione S-transferase was expressed in bacteria and affinity purified on a glutathione column. The affinity-purified fusion protein was used to prepare rabbit antiserum (MAPlB489-3) recognizing the N-terminal region of mouse MAP1B. To obtain antibodies to LC proteins, New
Zealand White rabbits were immunized and bled by standard techniques. Tubulin was detected with a commercially available mouse monoclonal antibody to a-tubulin (clone DM1A, Sigma). Detection of Proteins. For results shown in Fig. 5a , dissected cerebella were homogenized in 25 mM Tris-HCl, pH 7.4, containing 25 ,M leupeptin, 1 mM EGTA, 1 mM phenylmethanesulfonyl fluoride, and 2% (vol/vol) 2-mercaptoethanol prior to heating at 98°C for 10 min. After removal of precipitated proteins by centrifugation, heat-stable proteins were analyzed on 10% polyacrylamide gels in the presence of SDS. For results shown in Fig. 5b , whole brain extracts were dissolved in SDS-containing buffer and electrophoresed on SDS/5-16% polyacrylamide gels and blotted onto nitrocellulose filters. Immunoblotting was performed by conventional methods.
RESULTS

Generation of Mice Carrying a Mutation in the Maplb
Locus. To generate mice carrying a mutation in the Maplb gene we constructed a gene-targeting vector by introducing a neomycin phosphotransferase (neo) expression cassette into a fragment of the cloned genomic locus of mouse Maplb (ref. 17; Fig. la) . If the neo cassette-containing sequence integrated into the genomic locus, it would create a premature termination codon corresponding to codon 571 of the Maplb coding region. The gene targeting vector was introduced into mouse embryonic stem cell line E14-1 by electroporation. Colonies which grew in the presence of G418 and gancyclovir were isolated, grown, and examined for the desired gene modification initially by a PCR-based method using a primer located in the neo cassette and then by a second primer in genomic DNA outside the region of homology between the target and input DNA (Fig. la) cell lines were grown and their DNA was used for Southernblot hybridization. These results (not shown) confirmed that all of them had undergone a gene-targeting event. Two separate cell lines (M3407 and M5309), derived from independent gene-targeting events, were used to generate chimeric mice by injection into embryos derived from C57BL/6J (B6) animals. Chimeric males were, in turn, mated with B6 females, and germ-line transmission of the embryonic stem cell genome was assessed by coat color of the resulting offspring. Fourteen of the 16 chimeric males transmitted the embryonic stem cell genome through their germ line. DNA from these F1 animals was examined to determine if any of them contained the modified Maplb allele. Results from one such experiment are shown in Fig. lb . All of the animals contained a 2.0-kb band corresponding to the normal locus. Several of the animals (lanes 1, 2, 4, 6, 7, and 8) also contained a second band at 3.8 kb corresponding to the modified allele. These mice are heterozygous for the Maplb modification designated Maplb571. The heterozygous mice were interbred and the heterozygous F2 offspring were used for the analyses described below.
Phenotypes of Maplb571 Heterozygotes. To understand the phenotypic effects of the mutated Maplb allele, we followed the heterozygous animals and their wild-type littermates for more than a year. It should be noted that all of these animals had variable genetic contributions from the 129/J and C57BL/6J strains of mice. We observed that the heterozygous animals of both sexes, of various ages, as a group were inhibited in their growth as determined by the fact that they weighed 10-50% less than their age-and sex-matched wild-type littermates (Fig. 2a) . Twenty-eight of the 140 heterozygous animals (20%) had gross deformities of the ocular orbs. In some animals only one orb was affected, while in others both orbs were affected. Those mice which exhibited disorders of both orbs failed to respond to visual threats, suggesting that they have lost their visual acuity. This subset of heterozygous animals also exhibited a number of other distinctive phenotypic characteristics and were lethargic in their movement, exhibited an ataxic gait, and had a mild to severe spastic tremor of the hind limbs suggestive of cerebellar dysfunction. Some of do&. 'vo * 
Among the affected animals the degree of severity of these phenotypes was variable. None of the wild-type littermates had any of these phenotypes. These results suggest that the Maplb mutation we introduced is capable of acting in a dominant fashion with variable expressivity.
To ascertain the anatomical basis for the phenotypes observed, we dissected the whole brains of several heterozygous animals and examined them for possible gross morphological abnormalities. The phenotypically abnormal animals had abnormalities in the shape and size of the cerebellum; notably, an attenuated, flattened cerebellar hemisphere and vermis in comparison with wild-type littermates (Fig. 2b ). An enlargement of the olfactory bulb was observed in a few cases. The hippocampus was indistinguishable in wild-type and heterozygous animals.
Histological and Immunological Analysis. To understand the basis for the various abnormalities observed in the affected heterozygous animals, the parts of the brain in which MAPlB was known to be expressed were examined at the histological level by light microscopy and by using antibodies directed against MAP1B, MAPMA, MAP2, and some neurofilament proteins. The changes that we observed are described below.
Histologically, abnormalities of the cerebellum were the most profound of all the areas affected in the brain. The most striking difference between wild-type and heterozygous animals was in the morphology of the Purkinje cells. Although the overall numbers of Purkinje cells were similar in the two groups of animals, cell bodies in the heterozygotes had lost their flask-shaped appearance (Fig. 2c) and appeared flattened (Fig. 2d) .
To examine the basis for differences in Purkinje cell morphology, sections from wild-type and heterozygous animal brains were analyzed for MAPlB and MAPlA expression by using immunohistochemical methods. When antibodies directed against a nonnphosphorylated MAPlB epitope (designated 3G5) were used, the wild-type control showed a normal MAPlB staining pattern as well as normal-appearing Purkinje cell somata and dendrites (Fig. 3 a and c) (1996) Proc. Natl. Acad. Sci. USA 93 (1996) 1273 heterozygous animal, however, showed an overall lack of staining with the exception of a rare Purkinje cell (see Fig. 3 b and d). Similar results were obtained when we used antibodies directed against a phosphorylated epitope (designated 6D4; results not shown). When antibodies against MAPlA were used the Purkinje cells of heterozygous animals were found to have somewhat attenuated, truncated dendritic processes with decreased branching (see Fig. 3 f and h). Staining with antibodies directed against MAP2 (Fig. 4 a and When the olfactory tissue in normal animals was examined, the MAPlB antibodies moderately labeled the granular layer, the glomerular layer, and the olfactory nerve layer. Heavy labeling was observed in the external plexiform layer, the mitral cell layer, and the tufted cell layer, which had extensions into the glomeruli (Fig. 4c) . The 6D4 antibodies revealed no such staining in the affected Mablb571 heterozygous animals (Fig. 4d) .
Staining of the hippocampus in the wild-type animals with the 6D4 antibody revealed staining in the dendrites of all pyramidal cells (Fig. 4e ) and an occasional cell body. No such staining was observed in the affected heterozygote (Fig. 4f) .
Histological examination of the retina in the affected animals revealed that the internal nuclear layer as well as the external nuclear layer were disorganized compared with the wild-type littermates. We also observed a clear loss of demarcation of the external plexiform layer (Fig. 4 g and h) .
The histochemical analysis suggested that despite the presence of a single functional copy of Maplb, the MAPlB expression pattern in several parts of the brain is profoundly affected. To determine the effect of the mutation on protein expression, we prepared cell extracts from brains of normal and heterozygous animals and conducted immunoblot analysis using antibodies directed against MAP1B, the N-terminal 150 amino acids of MAPlB (MAPlB 489-3), MAP2 and Alz5O, LC1, LC2, LC3, and tubulin. The Alz50 antibody reacts with all forms of tau, has some cross-reactivity to MAP2, and recognizes a 120-kDa protein termed FAC (18). The results are presented in Fig. 5 . While the levels of tau and MAP2 proteins were unaltered in the heterozygotes, the level of MAPlB was reduced by about half as measured by 3G5 antibodies (Fig. 5a) (4, 20) . Therefore, the altered dosage of MAPlB in Maplb571 heterozygotes might be expected to result in altered levels of MAPlB as well as MAP1A. We indeed observed such a reduction in the levels of these two proteins at least at the histochemical level (Figs. 3 and 4) . Since MAP1 proteins are normally expressed in the brain, we postulate that the embryonic lethality is the result of failure of normal brain development. The fact that we did not detect any homozygous embryos at day 8.5 of embryonic development is consistent with this view. Our histochemical examination permits us to correlate the absence of MAPlB expression in Purkinje cells with the neurological phenotype. Since these cells have dendrites, it appears that MAPlB is not essential for dendrite formation but is nevertheless essential for normal cell function. These observations are consistent with the idea that MAPlB plays an important role in neuronal plasticity. The ocular phenotype observed in some of the heterozygous animals can be explained by the altered structure of the eye. It is possible that the absence of MAPlB in other parts of the brain (e.g., olfactory bulb and hippocampus) would also cause other abnormalities. Two possible explanations for the mechanism by which Maplb571 heterozygotes exhibit the observed phenotypic characteristics can be proposed. One possibility is that the Maplb571 mutation results in a null mutation such that the concomitant 50% reduction in the amount of MAPlB or LC1 is insufficient for assembly of normal MAP1B. The second alternative is that the mutation causes the production of a truncated polypeptide which by virtue of the presence of LC1 binding sites can prevent the function of the otherwise normal MAPlB protein derived from the normal allele. Despite the use of three different antibodies, one ofwhich is specific for the N-terminal 150 amino acids of the MAPlB heavy chain, we did not detect any truncated protein. This makes it unlikely that the mutation acts in a dominant-negative fashion, and we conclude that the phenotypes that we observe are most likely the result of haploinsufficiency of MAPlB heavy chain, LC1, or both.
Mice with a mutation in another neuronal MAP, tau, have been described (21). Mice which are homozygous for a null mutation in this gene have a normal nervous system but exhibit occasional microtubule instability in some small-caliber axons.
Increases in the levels of MAPlA have been observed in these tau-deficient mice. The dramatic differences in the phenotypes of the tau-deficient and Maplb mutant mice might reflect different functional roles of these proteins, and they underscore the importance of gene-targeted mice in understanding the in vivo roles of different gene products.
The availability of a Maplb mutant mouse provides a unique model for the study of developmental implications of mutations in the neuronal cytoskeleton on brain development and morphology and might provide clues to the etiology of human disorders in which these neuronal cell types are affected.
